Hepatocellular Carcinoma Post-Transarterial Chemoembolization and Diffusion-Weighted Imaging: Therapy Outcome Prediction and Tumor Response Assessment
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Hepatocellular Carcinoma Post-Transarterial Chemoembolization and Diffusion-Weighted Imaging: Therapy Outcome Prediction and Tumor Response Assessment ; volume:02 ; number:03 ; year:2018
Konferenz: PAIRS Annual Meeting; 2018-02-21; Grand Hyatt Hotel, Dubai UAE
The Arab journal of interventional radiology ; 02, Heft 03 (2018)
- Contributor
-
Temraz, Hesham Abdelmonem Elsayed
Houseni, Mohamed Mohame
- DOI
-
10.1055/s-0041-1730693
- URN
-
urn:nbn:de:101:1-2021081212120072937792
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Temraz, Hesham Abdelmonem Elsayed
- Houseni, Mohamed Mohame
Other Objects (12)
Prediction of hepatocellular carcinoma response to transarterial chemoembolization with intravoxel incoherent motion diffusion-weighted imaging
Diffusion-weighted imaging of hepatocellular carcinoma before and after transarterial chemoembolization: role in survival prediction and response evaluation
Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
Diagnostic accuracy of intermediate b-value diffusion-weighted imaging for detection of residual hepatocellular carcinoma following transarterial chemoembolization with drug-eluting beads
Diffusion-weighted imaging compared to dynamic MRI in early response assessment of locoregional therapy (by trans-arterial chemoembolization & microwave ablation) of hepatocellular carcinoma
Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma
Prognosis of transarterial chemoembolization-sorafenib compared to transarterial chemoembolization-alone in hepatocellular carcinoma stage C: a systematic review
PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma
Transarterial chemoembolization with molecular targeted therapies plus camrelizumab for recurrent hepatocellular carcinoma
Applicability of scoring systems predicting outcome of transarterial chemoembolization for hepatocellular carcinoma
Obstructive Jaundice Following Transarterial Chemoembolization for Hepatocellular Carcinoma with Bile Duct Invasion
Prediction of hepatocellular carcinoma response to transarterial chemoembolization with intravoxel incoherent motion diffusion-weighted imaging
Diffusion-weighted imaging of hepatocellular carcinoma before and after transarterial chemoembolization: role in survival prediction and response evaluation
Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
Diagnostic accuracy of intermediate b-value diffusion-weighted imaging for detection of residual hepatocellular carcinoma following transarterial chemoembolization with drug-eluting beads
Diffusion-weighted imaging compared to dynamic MRI in early response assessment of locoregional therapy (by trans-arterial chemoembolization & microwave ablation) of hepatocellular carcinoma
Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma
Prognosis of transarterial chemoembolization-sorafenib compared to transarterial chemoembolization-alone in hepatocellular carcinoma stage C: a systematic review
PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma
Transarterial chemoembolization with molecular targeted therapies plus camrelizumab for recurrent hepatocellular carcinoma
Applicability of scoring systems predicting outcome of transarterial chemoembolization for hepatocellular carcinoma
Obstructive Jaundice Following Transarterial Chemoembolization for Hepatocellular Carcinoma with Bile Duct Invasion
Prediction of hepatocellular carcinoma response to transarterial chemoembolization with intravoxel incoherent motion diffusion-weighted imaging
Diffusion-weighted imaging of hepatocellular carcinoma before and after transarterial chemoembolization: role in survival prediction and response evaluation
Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
Diagnostic accuracy of intermediate b-value diffusion-weighted imaging for detection of residual hepatocellular carcinoma following transarterial chemoembolization with drug-eluting beads
Diffusion-weighted imaging compared to dynamic MRI in early response assessment of locoregional therapy (by trans-arterial chemoembolization & microwave ablation) of hepatocellular carcinoma
Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma
Prognosis of transarterial chemoembolization-sorafenib compared to transarterial chemoembolization-alone in hepatocellular carcinoma stage C: a systematic review
PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma
Transarterial chemoembolization with molecular targeted therapies plus camrelizumab for recurrent hepatocellular carcinoma
Applicability of scoring systems predicting outcome of transarterial chemoembolization for hepatocellular carcinoma